Pro Share Advisors LLC Arcutis Biotherapeutics, Inc. Transaction History

Pro Share Advisors LLC

$48.7 Billion
Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 26,414 shares of ARQT stock, worth $539,638. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,414

Previous 28,622 7.71%

Holding current value

$539,638

Previous $447,000 17.23%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	SELL	$12.59 - $16.6 $27,798 - $36,652	-2,208 Reduced 7.71%	26,414 $370,000
Q1 2025 May 08, 2025	SELL	$11.4 - $17.29 $82,023 - $124,401	-7,195 Reduced 20.09%	28,622 $447,000
Q4 2024 Feb 13, 2025	BUY	$8.31 - $14.99 $73,402 - $132,406	8,833 Added 32.73%	35,817 $498,000
Q3 2024 Nov 13, 2024	BUY	$8.32 - $11.0 $76,918 - $101,695	9,245 Added 52.12%	26,984 $250,000
Q2 2024 Aug 13, 2024	SELL	$7.24 - $12.53 $23,537 - $40,735	-3,251 Reduced 15.49%	17,739 $164,000
Q1 2024 May 08, 2024	BUY	$3.25 - $11.77 $6,077 - $22,009	1,870 Added 9.78%	20,990 $208,000
Q4 2023 Feb 14, 2024	BUY	$1.84 - $4.82 $15,478 - $40,545	8,412 Added 78.56%	19,120 $61,000
Q3 2023 Nov 13, 2023	BUY	$5.31 - $10.98 $249 - $516	47 Added 0.44%	10,708 $56,000
Q2 2023 Aug 10, 2023	BUY	$7.51 - $15.0 $80,064 - $159,915	10,661 New	10,661 $101,000
Q4 2022 Feb 02, 2023	BUY	$13.96 - $20.4 $144,890 - $211,731	10,379 New	10,379 $153,000
Q2 2022 Aug 01, 2022	SELL	$16.33 - $22.2 $169,848 - $230,902	-10,401 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$14.38 - $22.79 $39,199 - $62,125	-2,726 Reduced 20.77%	10,401 $200,000
Q4 2021 Feb 08, 2022	SELL	$14.98 - $25.5 $17,197 - $29,274	-1,148 Reduced 8.04%	13,127 $272,000
Q3 2021 Nov 12, 2021	SELL	$19.28 - $27.1 $37,056 - $52,086	-1,922 Reduced 11.87%	14,275 $341,000
Q2 2021 Aug 13, 2021	BUY	$24.42 - $34.75 $74,944 - $106,647	3,069 Added 23.38%	16,197 $442,000
Q1 2021 May 14, 2021	BUY	$24.47 - $36.98 $44,266 - $66,896	1,809 Added 15.98%	13,128 $380,000
Q4 2020 Feb 09, 2021	BUY	$17.82 - $31.73 $201,704 - $359,151	11,319 New	11,319 $318,000

Others Institutions Holding ARQT

# of Institutions

241

Shares Held

131M

Call Options Held

407K

Put Options Held

216K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $1.23B
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Arcutis Biotherapeutics, Inc. Transaction History